170 related articles for article (PubMed ID: 19179877)
1. Anti-Saccharomyces cerevisiae antibodies status is associated with oral involvement and disease severity in Crohn disease.
Russell RK; Ip B; Aldhous MC; MacDougall M; Drummond HE; Arnott ID; Gillett PM; McGrogan P; Weaver LT; Bisset WM; Mahdi G; Wilson DC; Satsangi J
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):161-7. PubMed ID: 19179877
[TBL] [Abstract][Full Text] [Related]
2. Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease.
Gologan S; Iacob R; Preda C; Vadan R; Cotruta B; Catuneanu AM; Iacob S; Constantinescu I; Gheorghe L; Iobagiu S; Gheorghe C; Diculescu M
J Gastrointestin Liver Dis; 2012 Mar; 21(1):39-44. PubMed ID: 22457858
[TBL] [Abstract][Full Text] [Related]
3. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations.
Walker LJ; Aldhous MC; Drummond HE; Smith BR; Nimmo ER; Arnott ID; Satsangi J
Clin Exp Immunol; 2004 Mar; 135(3):490-6. PubMed ID: 15008984
[TBL] [Abstract][Full Text] [Related]
4. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
[TBL] [Abstract][Full Text] [Related]
5. Targeting tissular immune response improves diagnostic performance of anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease.
Bertin D; Grimaud JC; Lesavre N; Benelmouloud C; Desjeux A; Garcia S; Desplat-Jégo S
PLoS One; 2013; 8(11):e80433. PubMed ID: 24303014
[TBL] [Abstract][Full Text] [Related]
6. Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.
Paul S; Boschetti G; Rinaudo-Gaujous M; Moreau A; Del Tedesco E; Bonneau J; Presles E; Mounsef F; Clavel L; Genin C; Flourié B; Phelip JM; Nancey S; Roblin X
J Crohns Colitis; 2015 Jun; 9(6):445-51. PubMed ID: 25895876
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic role and clinical association of ASCA and ANCA in Brazilian patients with inflammatory bowel disease.
Nisihara RM; de Carvalho WB; Utiyama SR; Amarante H; Baptista ML
Dig Dis Sci; 2010 Aug; 55(8):2309-15. PubMed ID: 19826949
[TBL] [Abstract][Full Text] [Related]
8. Anti-Saccharomyces cerevisiae Antibodies as a Prognostic Biomarker in Children With Crohn Disease.
Chandrakumar A; Georgy M; Agarwal P; 't Jong GW; El-Matary W
J Pediatr Gastroenterol Nutr; 2019 Jul; 69(1):82-87. PubMed ID: 30789863
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic role and clinical correlates of anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (p-ANCA) in Italian patients with inflammatory bowel diseases.
Saibeni S; Folli C; de Franchis R; Borsi G; Vecchi M
Dig Liver Dis; 2003 Dec; 35(12):862-8. PubMed ID: 14703881
[TBL] [Abstract][Full Text] [Related]
10. Anti-Saccharomyces cerevisiae antibody does not differentiate between Crohn's disease and intestinal tuberculosis.
Makharia GK; Sachdev V; Gupta R; Lal S; Pandey RM
Dig Dis Sci; 2007 Jan; 52(1):33-9. PubMed ID: 17160471
[TBL] [Abstract][Full Text] [Related]
11. Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases.
Bartůnková J; Kolárová I; Sedivá A; Hölzelová E
Clin Immunol; 2002 Feb; 102(2):162-8. PubMed ID: 11846458
[TBL] [Abstract][Full Text] [Related]
12. A prospective comparative study of ASCA and pANCA in Chinese and Caucasian IBD patients.
Lawrance IC; Murray K; Hall A; Sung JJ; Leong R
Am J Gastroenterol; 2004 Nov; 99(11):2186-94. PubMed ID: 15555001
[TBL] [Abstract][Full Text] [Related]
13. Optimising the diagnostic value of anti-Saccharomyces cerevisiae-antibodies (ASCA) in Crohn's disease.
Klebl FH; Bataille F; Hofstädter F; Herfarth H; Schölmerich J; Rogler G
Int J Colorectal Dis; 2004 Jul; 19(4):319-24. PubMed ID: 14745572
[TBL] [Abstract][Full Text] [Related]
14. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.
Sipeki N; Davida L; Palyu E; Altorjay I; Harsfalvi J; Szalmas PA; Szabo Z; Veres G; Shums Z; Norman GL; Lakatos PL; Papp M
World J Gastroenterol; 2015 Jun; 21(22):6952-64. PubMed ID: 26078573
[TBL] [Abstract][Full Text] [Related]
15. Significance of anti-sacharomices cerevisiae antibodies (ASCA) in patients with inflammatory bowel diseases in Romania.
Preda CM; Diculescu M; Mirea V; Marica C; Vermeire S; Rutgeerts P; Oproiu A
Rom J Gastroenterol; 2005 Mar; 14(1):23-6. PubMed ID: 15800689
[TBL] [Abstract][Full Text] [Related]
16. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease.
Israeli E; Grotto I; Gilburd B; Balicer RD; Goldin E; Wiik A; Shoenfeld Y
Gut; 2005 Sep; 54(9):1232-6. PubMed ID: 16099791
[TBL] [Abstract][Full Text] [Related]
17. Reappraisal of antibodies against Saccharomyces cerevisiae (ASCA) as persistent biomarkers in quiescent Crohn's disease.
Duarte-Silva M; Afonso PC; de Souza PR; Peghini BC; Rodrigues-Júnior V; de Barros Cardoso CR
Autoimmunity; 2019 Feb; 52(1):37-47. PubMed ID: 30884988
[TBL] [Abstract][Full Text] [Related]
18. Anti-Saccharomyces cerevisiae antibodies in inflammatory bowel disease: a family study.
Seibold F; Stich O; Hufnagl R; Kamil S; Scheurlen M
Scand J Gastroenterol; 2001 Feb; 36(2):196-201. PubMed ID: 11252413
[TBL] [Abstract][Full Text] [Related]
19. Anti-Saccharomyces cerevisiae antibody titers are stable over time in Crohn's patients and are not inducible in murine models of colitis.
Müller S; Styner M; Seibold-Schmid B; Flogerzi B; Mähler M; Konrad A; Seibold F
World J Gastroenterol; 2005 Nov; 11(44):6988-94. PubMed ID: 16437604
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
Peeters M; Joossens S; Vermeire S; Vlietinck R; Bossuyt X; Rutgeerts P
Am J Gastroenterol; 2001 Mar; 96(3):730-4. PubMed ID: 11280542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
